CEN Biotech Inc
CENBF · PINKDay Range
52 Week Range
Market Cap
6.53KUSD
About
General Information
Type
Common Stock
Exchange
PINK
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
-
CUSIP
-
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
December
IPO date
-
Updated At
-
Highlights
PE Ratio
-
PEG Ratio
-
Book Value
-0.03
Dividend Share
-
Dividend Yield
-
Earnings Share
-0.03
Wall Street Target Price
-
EPS Estimate Current Year
0
EPS Estimate Next Year
0
EPS Estimate Current Quarter
0
EPS Estimate Next Quarter
0
Most Recent Quarter
-
Profitability
Revenue TTM
1,033,034
Gross Profit TTM
626,867
EBITDA
-889,849
Profit Margin
-299.69%
Return On Assets TTM
-10.10%
Return On Equity TTM
0.00%
Revenue Per Share TTM
0.017
Qtly Revenue Growth YOY
-50.10%
Diluted Eps TTM
-0.03
Qtly Earnings Growth YOY
0.00%
Valuation
Trailing PE
0.00
Forward PE
0
Price Sales TTM
0.0063
Price Book MRQ
0
Enterprise Value Revenue
6
Enterprise Value EBITDA
-2
Peers analysis
- MKGAFMERCK Kommanditgesellschaft auf Aktien
147.55
1.93% - HLNHaleon plc
9.18
1.83% - MKKGYMerck KGaA ADR
29.06
0.73% - TAKTakeda Pharmaceutical Co Ltd ADR
13.08
0.23% - TEVATeva Pharma Industries Ltd ADR
21.01
0.07%
- TEVJFTeva Pharmaceutical Industries Limited
20.29
0.00% - TKPHFTakeda Pharmaceutical Co. Ltd.
24.25
-7.34% - NBIXNeurocrine Biosciences Inc
139.50
-2.51% - ZTSZoetis Inc
165.09
-0.73% - SDZNYSandoz Group AGSa
42.07
-0.36%
